Introduction: When to Seek Diagnostic Evaluation

If your child experiences persistent joint pain, back discomfort, or morning stiffness that doesn’t go away quickly, it’s time to talk with a doctor. Juvenile spondyloarthritis, often shortened to JSpA, is a group of inflammatory diseases that cause arthritis before age 16 and may continue into adult life. Because the signs can be unpredictable and sometimes come and go without an obvious pattern, parents and children may initially dismiss them as growing pains or sports-related soreness.^[1]

Children who should undergo diagnostic evaluation include those experiencing pain in the lower body joints such as the hips, knees, ankles, or heels, especially if the pain improves with activity but worsens with rest. Pain at sites where tendons and ligaments attach to bones—a condition called enthesitis—is particularly important to notice. Common locations include the heel, the area around the kneecap, and the bottom of the foot.^[2]

Boys are more frequently affected than girls, and symptoms typically appear around ages 10 to 13, though they can develop earlier or later. If your child also experiences eye pain, redness, or sensitivity to light, or if there’s a family history of inflammatory diseases, seeking medical attention becomes even more important. Early morning stiffness lasting more than a few minutes, difficulty standing up straight, or persistent fatigue alongside joint pain are all signals that warrant a visit to a healthcare provider.^[4]

Because juvenile spondyloarthritis encompasses several related conditions—including enthesitis-related arthritis, juvenile ankylosing spondylitis, psoriatic arthritis, reactive arthritis, and arthritis associated with inflammatory bowel disease—the diagnostic journey requires careful attention to multiple symptoms and body systems.^[1][3]

Classic Diagnostic Methods

There is no single test that can definitively diagnose juvenile spondyloarthritis, which makes the diagnostic process more complex than for some other conditions. Doctors rely on a combination of medical history, physical examination, laboratory tests, and imaging studies to build a complete picture. The goal is not only to confirm the presence of inflammatory arthritis but also to distinguish JSpA from other types of joint problems in children.^[4]

Medical History and Physical Examination

The diagnostic journey typically begins with a detailed conversation about your child’s symptoms. The doctor will ask when the joint pain started, which joints are affected, whether the pain is worse at certain times of day, and if it improves with movement. They’ll inquire about any family history of arthritis or related conditions, recent infections, skin problems like psoriasis, or digestive issues such as chronic diarrhea or abdominal pain.^[4][7]

During the physical examination, the doctor carefully checks for joint swelling, warmth, pain, and stiffness. They pay special attention to the sites where tendons and ligaments attach to bones, pressing gently on areas like the heels, around the kneecaps, and the bottoms of the feet to check for tenderness. The spine and lower back are examined for flexibility and signs of inflammation. The doctor also looks for signs that might suggest associated conditions, such as skin changes, eye redness, or abdominal tenderness.^[2][7]

Laboratory Testing

Blood tests play an important supporting role in diagnosing juvenile spondyloarthritis, even though they cannot confirm the diagnosis on their own. One of the most significant tests looks for a genetic marker called HLA-B27. This is a protein found on the surface of certain immune cells. Studies show that 60 to 90 percent of patients with arthritis affecting the spine carry this gene marker, and about 80 to 90 percent of children with juvenile ankylosing spondylitis test positive for HLA-B27.^[2][4][6]

However, having the HLA-B27 gene doesn’t mean a child will definitely develop the disease. Only a small fraction of people who carry this marker ever develop arthritis. Conversely, some children with juvenile spondyloarthritis test negative for HLA-B27. This means the test provides helpful information but cannot be used alone to make or rule out a diagnosis.^[2][6]

Doctors may also order other blood tests to measure inflammation levels in the body. The erythrocyte sedimentation rate (ESR or sed rate) measures how quickly red blood cells settle at the bottom of a test tube—faster settling indicates inflammation. Another test checks for rheumatoid factor (RF), an antibody found in some types of arthritis. Importantly, rheumatoid factor is typically absent in juvenile spondyloarthritis, which helps distinguish it from other forms of juvenile arthritis.^[12][16]

Imaging Studies

Because inflammation in large joints like the hips and spine can be difficult or impossible to see or feel during a physical exam, imaging becomes crucial for diagnosis. When arthritis affects these deeper structures, swelling may not be visible on the outside, making it necessary to look inside the body using medical imaging technology.^[2][7]

X-rays are often the first imaging test performed. They can show changes in the bones and joints, including damage to the sacroiliac joints where the spine meets the pelvis. However, changes may not appear on X-rays in the early stages of disease, which can delay diagnosis. X-rays are particularly useful for detecting later-stage disease when bones have begun to change or fuse together.^[4][12]

When X-rays don’t show clear abnormalities but symptoms suggest juvenile spondyloarthritis, doctors may order more sensitive imaging tests. Magnetic resonance imaging (MRI) can detect inflammation in joints and soft tissues much earlier than X-rays. An MRI uses powerful magnets and radio waves to create detailed pictures of the inside of the body without using radiation. This test is especially valuable for seeing inflammation in the spine and sacroiliac joints before permanent bone changes occur.^[2][7]

Ultrasound and CT scans (computed tomography) may also be used to examine joints. Ultrasound uses sound waves to create real-time images and can be particularly helpful for looking at inflammation where tendons attach to bones. CT scans provide detailed cross-sectional images of the body and may be used when more detail is needed than X-rays can provide.^[2][7]

Distinguishing JSpA from Other Conditions

Because joint pain and stiffness can have many causes in children, doctors work carefully to rule out other possibilities. Juvenile spondyloarthritis must be distinguished from other forms of juvenile idiopathic arthritis (JIA), which is an umbrella term for several types of chronic arthritis in children. Enthesitis-related arthritis, one of the most common forms of JSpA in children, is actually classified as a subtype of JIA.^[2][7]

The pattern of joint involvement provides important clues. Juvenile spondyloarthritis typically affects the lower body—especially the knees, ankles, hips, and heels—and often involves inflammation at tendon and ligament attachment sites. The presence of enthesitis, inflammation of the spine or sacroiliac joints, absence of rheumatoid factor, and the HLA-B27 genetic marker help distinguish JSpA from other types of juvenile arthritis.^[2][6][7]

Doctors also investigate whether the arthritis might be associated with other conditions that fall under the spondyloarthritis umbrella. They look for signs of psoriasis (a skin condition causing red, scaly patches), inflammatory bowel disease (causing abdominal pain, diarrhea, and weight loss), or a recent infection that might have triggered reactive arthritis. Each of these conditions can present with similar joint symptoms but requires slightly different management approaches.^[2][7]

Diagnostics for Clinical Trial Qualification

When children with juvenile spondyloarthritis are being considered for enrollment in clinical trials, additional diagnostic criteria and tests may be required beyond those used for standard clinical diagnosis. Clinical trials are research studies that test new treatments or better ways to use existing treatments. They follow strict rules about who can participate to ensure the study results are reliable and meaningful.^[9]

Classification Systems and Eligibility

Three main classification systems are used for juvenile spondyloarthritis in research settings. The most widely used is the International League of Associations for Rheumatology (ILAR) classification of juvenile idiopathic arthritis. This system includes enthesitis-related arthritis as one category, which many researchers consider synonymous with juvenile spondyloarthritis. Clinical trials may require that a child meet specific ILAR criteria for enthesitis-related arthritis before they can enroll.^[5][3]

Different trials may define disease activity differently, so children need to undergo testing to confirm they meet the study’s specific requirements. This might include documenting the number of actively inflamed joints, measuring the degree of enthesitis at various body sites, or confirming spine involvement through imaging. Some trials focus only on children with certain subtypes of JSpA, such as those with confirmed juvenile ankylosing spondylitis (requiring proof of spine involvement on imaging), while others may include the broader category of enthesitis-related arthritis.^[2][7]

Baseline Testing and Biomarkers

Before starting a clinical trial, children typically undergo comprehensive baseline testing. This creates a starting point against which future changes can be measured. Blood tests repeated at baseline often include inflammatory markers like ESR and C-reactive protein (CRP), HLA-B27 testing if not already done, and general health indicators such as complete blood count, liver function, and kidney function. These help ensure the child is healthy enough for the trial and establish their disease state at the beginning.^[9]

Some clinical trials investigate potential biomarkers—measurable biological signals that might predict disease severity, progression, or response to treatment. While no specific biomarkers for juvenile spondyloarthritis have been validated for routine clinical use, research continues to search for better ways to identify which children will benefit most from particular treatments. Trial participants may have additional blood or other samples collected specifically to search for these markers.^[3]

Imaging Requirements

Many clinical trials require specific imaging studies to confirm diagnosis and establish baseline disease status. For studies focused on axial disease (spine and sacroiliac joint involvement), MRI scans of the spine and pelvis are often mandatory. These scans must show active inflammation or structural damage consistent with spondyloarthritis. X-rays may also be required to document any existing bone changes.^[2][7]

For trials examining peripheral arthritis and enthesitis, ultrasound examinations may be performed to objectively measure inflammation at tendon and ligament insertion sites. These imaging studies not only help confirm eligibility but also provide objective measures that can be tracked throughout the trial to see if the treatment is working.

Disease Activity Measures

Clinical trials use standardized tools to measure disease activity, and qualifying for a trial often requires a minimum level of active disease. Common measures include counting the number of swollen and tender joints, measuring how well the child can perform daily activities, and using scales that rate pain and overall disease activity. Parents and children may complete questionnaires about quality of life, school participation, and how the disease affects daily functioning.^[5]

Physical examination findings such as range of motion in the spine, chest expansion (which can be limited in spinal arthritis), and measurement of enthesitis at standardized sites are documented carefully. These measurements will be repeated throughout the trial to track whether the treatment being studied makes a difference.

The specific diagnostic tests and qualification criteria vary considerably among different clinical trials. If you’re considering enrolling your child in a research study, the research team will explain exactly what tests are needed and whether your child meets the specific criteria for that particular trial.